OR WAIT null SECS
GNS and Servier announced a collaboration to advance drug discovery, translational, and clinical development efforts in Multiple Myeloma (MM).
The collaboration will address key questions about how MM progresses in different patient subpopulations. This work will initially leverage the GNS Gemini Digital Twin for MM developed using the rich clinico-genomic data from the Multiple Myeloma Research Foundation (MMRF) CoMMpass study.
Read more about the new partnership here.